Treatment of hepatitis c in the asian population with...

Details Treatment of hepatitis c in the asian population with... Treatment of hepatitis c in the asian population with...

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2487299

The use of recombinant IFN-beta for the production of a medicament for the treatment of HCV infection by subcutaneous administration to patients of Asian race, which failed to respond to a previous treatment with interferon -alpha, is herein reported. According to a preferred embodiment of the invention, this treatment can be better and further focused to those patients, which after 4 weeks of initial treatment with IFN-beta show HCV RNA clearance.

La présente invention concerne l'utilisation d'interféron bêta de recombinaison pour produire un médicament destiné à traiter l'infection due au VHC par administration sous-cutanée aux patients de race asiatique n'ayant pas répondu à un traitement précédent à l'interféron alpha. Selon un mode de réalisation préféré de la présente invention, ce traitement peut être mieux concentré, et de manière plus ciblée, sur les patients qui présentent une élimination de l'ARN-VHC après un traitement initial de quatre semaines.

Affiliated with

Also associated with

Rating

Treatment of hepatitis c in the asian population with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hepatitis c in the asian population with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hepatitis c in the asian population with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1714028